Author: Zacks Small Cap Research

1313233343555330 / 544 POSTS
By John Vandermosten, CFANASDAQ:TTNPREAD THE FULL TTNP RESEARCH REPORTSecond Quarter 2018 Financial and Operational ResultsTitan Pharmaceuticals, Inc. (NASDAQ:TTNP) reported second quarter 2018 results in its August 14th release and subsequently file ...
By David Bautz, PhDNASDAQ:MTPREAD THE FULL MTP RESEARCH REPORT HEREBusiness UpdateMidatech Pharma Plc (NASDAQ:MTP) is a specialty pharmaceutical company with three novel drug delivery technologies that improve bio-distribution and bio-delivery of dru ...
NASDAQ:CKPTYesterday, Checkpoint Therapeutics (NASDAQ:CKPT) announced preliminary safety and efficacy data from their ongoing Phase I/II trial for CK-101. CK-101 is the company’s most advanced candidate intended for non-small cell lung cancer (NSCLC) ...
By Brian Marckx, CFANASDAQ:BMRAREAD THE FULL BMRA RESEARCH REPORTQ4 2018: Legacy Biz Slows in Q4.Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and we’re intrigued)… Biomerica (NASDAQ:BMRA) reported financial results fo ...
NYSE:JTBeijing, China-based Jianpu Technology Inc.  (NYSE:JT) is an internet services provider that operates an open platform enabling individual users and small businesses to obtain information about selecting financial services and products and als ...
By David Bautz, PhDNASDAQ:BVXVREAD THE FULL BVXV RESEARCH REPORTBusiness UpdateFirst Subject Enrolled in Phase 3 Trial of M-001BiondVax Pharmaceuticals,Ltd. (NASDAQ:BVXV) is a biopharmaceutical company developing a universal influenza vaccine (M-001) ...
By David Bautz, PhDTSX:ATE.VREAD THE FULL ATE.V RESEARCH REPORTBusiness UpdateScientific Report on Phase 2b Trial of ATB-346On August 29, 2018, Antibe Therapeutics, Inc. (TSX:ATE.V) announced the availability of a comprehensive report summarizing the ...
By John Vandermosten, CFATSE:RVXREAD THE FULL RVX RESEARCH REPORTIn the Home Stretch Resverlogix Corp. (TSE:RVX) launched its Phase III BETonMACE trial in the fall of 2015 and for the last three years has steadily recruited patients now exceedin ...
By John Vandermosten, CFANASDAQ:TENXREAD THE FULL TENX RESEARCH REPORTSecond Quarter 2018 ReviewIn January, Tenax Therapeutics, Inc. (NASDAQ:TENX) announced its plan to advance the development of levosimendan for Pulmonary Hypertension associated wit ...
OTC:MRRCFToronto, Canada-based Maricann Group Inc. (OTC:MRRCF) is a vertically integrated company that produces legal marijuana-based products. Founded in 2013, the company has production facilities in Ontario, Canada, where it operates a medicinal c ...
1313233343555330 / 544 POSTS